Charcoal Max Australien - engelsk - Department of Health (Therapeutic Goods Administration)

charcoal max

premalife pty ltd t/a natural vitality australia - activated charcoal,carica papaya,foeniculum vulgare,peppermint oil,zingiber officinale -

HERBAL COUGH RELIEF Australien - engelsk - Department of Health (Therapeutic Goods Administration)

herbal cough relief

premalife pty ltd t/a natural vitality australia - achillea millefolium,echinacea purpurea,eupatorium perfoliatum,euphorbia hirta,glycyrrhiza glabra,inula helenium,plantago lanceolata,sambucus nigra,thymus vulgaris -

NPM AstressX Compound tablet bottle Australien - engelsk - Department of Health (Therapeutic Goods Administration)

npm astressx compound tablet bottle

premalife pty ltd t/a natural vitality australia - cyanocobalamin, quantity: 10 microgram; nicotinamide, quantity: 30 mg; pyridoxine hydrochloride, quantity: 12 mg (equivalent: pyridoxine, qty 9.87 mg); calcium pantothenate, quantity: 12 mg (equivalent: pantothenic acid, qty 10.99 mg); riboflavine, quantity: 10 mg; zinc amino acid chelate, quantity: 25 mg (equivalent: zinc, qty 5 mg); calcium amino acid chelate, quantity: 125 mg (equivalent: calcium, qty 25 mg); magnesium amino acid chelate, quantity: 225 mg (equivalent: magnesium, qty 45 mg); biotin, quant - tablet, film coated - excipient ingredients: povidone; magnesium stearate; calcium hydrogen phosphate dihydrate; crospovidone; hypromellose; macrogol 400; carnauba wax - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) multi vitamin and mineral supplement

ISOCIPRALINE isoprenaline hydrochloride 1.0 mg/5 mL injection solution ampoule Australien - engelsk - Department of Health (Therapeutic Goods Administration)

isocipraline isoprenaline hydrochloride 1.0 mg/5 ml injection solution ampoule

cipla australia pty ltd - isoprenaline hydrochloride, quantity: 1 mg - injection, solution - excipient ingredients: disodium edetate; sodium chloride; sodium citrate dihydrate; citric acid; hydrochloric acid; sodium hydroxide; water for injections - isocipraline is indicated: - for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy. - for serious episodes of heart block and adams-stokes attacks (except when caused by ventricular tachycardia or fibrillation) (see section 4.3 contraindications). - for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available (see section 4.3 contraindications). - for brochospasm occurring during anaesthesia. - as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cariodgenic shock (see section 4.4 special warnings and precautions for use).

ISOCIP isoprenaline hydrochloride 1.0 mg/5 mL injection solution ampoule Australien - engelsk - Department of Health (Therapeutic Goods Administration)

isocip isoprenaline hydrochloride 1.0 mg/5 ml injection solution ampoule

cipla australia pty ltd - isoprenaline hydrochloride, quantity: 1 mg - injection, solution - excipient ingredients: disodium edetate; sodium chloride; sodium citrate dihydrate; citric acid; hydrochloric acid; sodium hydroxide; water for injections - isocip is indicated: - for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy. - for serious episodes of heart block and adams-stokes attacks (except when caused by ventricular tachycardia or fibrillation) (see section 4.3 contraindications). - for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available (see section 4.3 contraindications). - for brochospasm occurring during anaesthesia. - as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cariodgenic shock (see section 4.4 special warnings and precautions for use).

ISOCIPRALINE isoprenaline hydrochloride 0.2 mg/1 mL injection solution ampoule Australien - engelsk - Department of Health (Therapeutic Goods Administration)

isocipraline isoprenaline hydrochloride 0.2 mg/1 ml injection solution ampoule

cipla australia pty ltd - isoprenaline hydrochloride, quantity: 0.2 mg - injection, solution - excipient ingredients: disodium edetate; sodium chloride; sodium citrate dihydrate; citric acid; hydrochloric acid; sodium hydroxide; water for injections - isocipraline is indicated: - for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy. - for serious episodes of heart block and adams-stokes attacks (except when caused by ventricular tachycardia or fibrillation) (see section 4.3 contraindications). - for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available (see section 4.3 contraindications). - for brochospasm occurring during anaesthesia. - as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cariodgenic shock (see section 4.4 special warnings and precautions for use).

ISOCIP isoprenaline hydrochloride 0.2 mg/1 mL injection solution ampoule Australien - engelsk - Department of Health (Therapeutic Goods Administration)

isocip isoprenaline hydrochloride 0.2 mg/1 ml injection solution ampoule

cipla australia pty ltd - isoprenaline hydrochloride, quantity: 200 microgram - injection, solution - excipient ingredients: disodium edetate; sodium chloride; sodium citrate dihydrate; citric acid; hydrochloric acid; sodium hydroxide; water for injections - isocip is indicated: - for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy. - for serious episodes of heart block and adams-stokes attacks (except when caused by ventricular tachycardia or fibrillation) (see section 4.3 contraindications). - for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available (see section 4.3 contraindications). - for brochospasm occurring during anaesthesia. - as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cariodgenic shock (see section 4.4 special warnings and precautions for use).

ORCIPRENALINE SYRUP Canada - engelsk - Health Canada

orciprenaline syrup

apotex inc - orciprenaline sulfate - syrup - 2mg - orciprenaline sulfate 2mg - selective beta 2-adrenergic agonists

ORCIPRENALINE SYRUP Canada - engelsk - Health Canada

orciprenaline syrup

aa pharma inc - orciprenaline sulfate - syrup - 2mg - orciprenaline sulfate 2mg - selective beta 2-adrenergic agonists

Isoprenaline HCl Macure 0,2 mg/ml inf. sol. (conc.) i.v. amp. Belgien - engelsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

isoprenaline hcl macure 0,2 mg/ml inf. sol. (conc.) i.v. amp.

macure pharma aps - isoprenaline hydrochloride 0,2 mg/ml - eq. isoprenaline 0,17 mg/ml - concentrate for solution for infusion - 0,2 mg/ml - isoprenaline hydrochloride 0.2 mg/ml - isoprenaline